400-920-2911 sales@csnpharm.cn
CAS No.: 945755-56-6
Synonyms: XL019
XL019 is a selective and potent JAK2 inhibitor with IC50 value of 2.2 nM, with less potency to JAK1, JAK3, FLT3 and PDGFRβ with IC50 values of 134.3 nM, 214.2 nM, 139.7 nM and 125.4 nM, respectively.
规格 | 价格 | 促销价格 | 库存 | 数量 |
---|
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00522574 | Myeloproliferative Disorders ... more >> Myelofibrosis Polycythemia Vera Thrombocythemia, Essential Collapse << | Phase 1 | Terminated(Due to emerging saf... more >>ety data) Collapse << | - | United States, California ... more >> UCSF - Division of Hematology/Oncology San Francisco, California, United States, 94143 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Mt. Sinai School of Medicine New York, New York, United States, 10029 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT00595829 | Polycythemia Vera | Phase 1 | Terminated | - | United States, California ... more >> UCLA School of Medicine, Center for Health Sciences Los Angeles, California, United States, 90095 UCSF - Division of Hematology/Oncology San Francisco, California, United States, 94143 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Michigan University of Michigan Health System Ann Arbor, Michigan, United States, 48109 United States, New York Weill Cornell Medical College New York, New York, United States, 10065 Collapse << |
实验方案
技术信息
CAS号 | 945755-56-6 | 储存条件 |
|
|||||
分子式 | C25H28N6O2 | 运输 | 蓝冰 | |||||
分子量 | 444.53 | 别名 | XL019 | |||||
溶解度 |
|
动物实验配方 |